Furthermore, in our previous study, FAK down-regulation inhibited leukemogenesis in breakpoint cluster region/Abelson leukemia virus (BCR/ABL)-transformed ALL cells and increased apoptosis and drug efficacy in pro-B ALL cells. This evidence concerns the gene PTK2 and acute lymphoblastic leukemia.